Structural Biology in Cancer Research

The primary aim of integrating structural biology into cancer research is to design and discover novel, effective drugs that can target cancer at the molecular level. By combining structural biology with molecular modeling, researchers can understand how cancer-related biomolecules function and interact, enabling precise drug design. This approach accelerates the development of targeted therapies with higher efficacy and fewer side effects. As a result, a significant portion of structural biology research today is focused on cancer, with many leading scientists dedicating their efforts to unraveling the molecular mechanisms behind the disease to drive innovation in cancer treatment.

 

    Related Conference of Structural Biology in Cancer Research

    September 08-09, 2025

    23rd International Conference on Structural Biology

    Frankfurt, Germany
    September 29-30, 2025

    21st World Congress on Structural Biology

    Aix-en-Provence, France

    Structural Biology in Cancer Research Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in